Roofstock

Roofstock Welcomes Andrew Schaffler as Chief Investment Officer

December 06, 2023 09:00 AM Eastern Standard Time OAKLAND, Calif.–(BUSINESS WIRE)–Roofstock, a leading real estate services and investment platform specializing in the single-family rental (SFR) sector, is thrilled to announce the appointment of Andrew Schaffler as Chief Investment Officer. In this strategic role, Mr. Schaffler will lead the investment team for Roofstock Capital Management and execute research-driven fund strategies in the SFR and build-to-rent sectors. … Continue reading Roofstock Welcomes Andrew Schaffler as Chief Investment Officer

Opportune

Matthew Childress Joins Opportune LLP as Chief Strategy Officer

December 06, 2023 09:00 AM Eastern Standard Time HOUSTON–(BUSINESS WIRE)–Opportune LLP, a leading global business advisory firm with preeminence in energy, announces the appointment of Matthew Childress as Chief Strategy Officer. In his new role, Mr. Childress will spearhead the execution of strategic growth initiatives at Opportune. “We are pleased to welcome Matthew to Opportune”Post this “We are pleased to welcome Matthew to Opportune,” said Josh Sherman, a … Continue reading Matthew Childress Joins Opportune LLP as Chief Strategy Officer

GWI

GWI Appoints New Chief Technology Officer, Nick Dearden

The appointment will drive further platform innovation in ease-of-use, richness of data, and intuitive AI tools for greater insight December 06, 2023 09:00 AM Eastern Standard Time LONDON–(BUSINESS WIRE)–GWI, the global consumer research platform, today announced that it has appointed Nick Dearden as Chief Technology Officer, based in its UK headquarters in London. “My most recent experience of transforming OAG’s product offering can be applied to GWI, … Continue reading GWI Appoints New Chief Technology Officer, Nick Dearden

Alentis Therapeutics

Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Velji brings more than 20 years of experience in biotech financial services December 06, 2023 08:00 AM Eastern Standard Time BASEL, Switzerland–(BUSINESS WIRE)–Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointed Chief Business Officer (CBO). He will lead corporate strategy, business development, and finance. Rizwan Velji, Chief Business Officer … Continue reading Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Ionpath

Ionpath Announces Executive Chair Appointment and CEO Promotion

Company names Paul Davy as CEO, appoints David Summa as Executive Chairman of the Board December 06, 2023 08:00 AM Eastern Standard Time MENLO PARK, Calif.–(BUSINESS WIRE)–Ionpath, a pioneer in high-plex spatial proteomics, today announced that Paul Davy, former Vice President of Customer Experience, has been appointed CEO of the company. Outgoing CEO David Summa is now Executive Chairman of Ionpath’s Board of Directors. “We … Continue reading Ionpath Announces Executive Chair Appointment and CEO Promotion